Explore
Validate
LearnHPA063731
antibody from Atlas Antibodies
Targeting: ANKRD17
FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA063731 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA063731, RRID:AB_2685106
- Product name
- Anti-ANKRD17
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human ANKRD17, Gene description: ankyrin repeat domain 17, Alternative Gene Names: FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16, Validated applications: ICC, Uniprot ID: O75179, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Proximity labelling of pro-interleukin-1α reveals evolutionary conserved nuclear interactions.
Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines
Wellens R, Tapia VS, Seoane PI, Bennett H, Adamson A, Coutts G, Rivers-Auty J, Lowe M, Green JP, Lopez-Castejon G, Brough D, Hoyle C
Nature communications 2024 Aug 8;15(1):6750
Nature communications 2024 Aug 8;15(1):6750
Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines
Saar M, Jaal J, Meltsov A, Laasfeld T, Lust H, Kasvandik S, Lavogina D
Pharmaceutics 2023;15(5):1485
Pharmaceutics 2023;15(5):1485
No comments: Submit comment
No validations: Submit validation data